Dogwood Therapeutics, Inc. (DWTX)
Develops drugs combining antivirals and anti-inflammatories to treat pain and fatigue disorders.
$1.55+0.01%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-68.0%
The outlook
DWTX is trading near its 52-week lows at $1.55, well below both its 50- and 200-day moving averages. Analyst coverage shows a wide disconnect: the average price target sits roughly 8× the current price, though consensus leans bearish overall. The stock's low valuation and distressed positioning reflect significant investor skepticism despite optimistic long-term price targets.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range3% of the way from its 52-week low to high
Price targetAvg target +803% vs current price
Analyst price target
~12-month · 3 analysts$14.00average target+803.2% vs now
Now $1.55
Low $12.00High $15.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$52.1M
52-wk high
$9.50
52-wk low
$1.28
50-day avg
$1.56
200-day avg
$3.23
Trailing P/E
1.3